Credit: Original article published here.According to the United States Renal Data System, use of home dialysis has increased since 2017. Across all payer types, the greatest growth has been seen in home hemodialysis. The Advancing American Kidney Health (AAKH) executive order set a goal of initiating home dialysis or preemptive kidney transplant for 80% of patients with incident end-stage renal disease (ESRD). While new payment models from the Centers for Medicare & Medicaid Services (CMS) reward payers for achievement of higher rates of home dialysis, use of home hemodialysis is lowest among patients with Medicare Advantage health insurance coverage: 1.3% versus 3.0% among patients with original Medicare fee-for-service (FFS) coverage without Medicaid. During a poster session at the National Kidney Foundation Spring Clinical Meetings 2023, Stephan Dunning, MBA, and colleagues at Outset Medical, Inc., San Jose, California, reported estimates of the per-member per-month (PMPM) costs for a Medicare Advantage health plan and 5-year savings generated by incentivizing home dialysis aligned with the AAKH goal. The poster was titled Home Hemodialysis Can Help Reduce Total Cost of Care Among Medicare Advantage Members With ESRD. The researchers modeled a Medicare Advantage health plan with 500 members on dialysis. They included inputs from